117906.
(a) For purposes of this section, the following definitions apply:(1) “Home-generated medical waste” includes home-generated pharmaceutical waste and home-generated sharps waste.
(2) “Home-generated pharmaceutical waste” means a prescription or over-the-counter human or veterinary home-generated pharmaceutical, as defined in Section 109925 or in the Federal Food, Drug, and Cosmetic Act, as amended (21 U.S.C. Sec. 321(g)(1)), that is a waste, as defined by Section 25124, derived from a household, including, but not limited to, a multifamily residence or household.
(3) “Home-generated sharps waste” means hypodermic
needles, pen needles, intravenous needles, lancets, and other devices that are used to penetrate the skin for the delivery of medications, that are wastes, as defined pursuant to Section 25124, derived from a household, including, but not limited to, a multifamily residence or household.
(4) “Stakeholder” means a person, including, but not limited to, a consumer, retailer, distributor, or healthcare provider or facility, who will be participating in a program developed pursuant to subdivision (b).
(b) (1) The California Environmental Protection Agency, in consultation with stakeholders, may develop a statewide program for the collection, transportation, and disposal of home-generated medical waste that complies with federal and state laws regulating the collection, transportation, and disposal of medical waste.
(2) The program developed pursuant to paragraph (1) shall not be implemented without appropriation by the Legislature in the annual Budget Act.